RCKT vs. BMRN
Compare and contrast key facts about Rocket Pharmaceuticals, Inc. (RCKT) and BioMarin Pharmaceutical Inc. (BMRN).
Performance
RCKT vs. BMRN - Performance Comparison
Loading graphics...
RCKT vs. BMRN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RCKT Rocket Pharmaceuticals, Inc. | 1.99% | -72.08% | -58.06% | 53.14% | -10.35% | -60.19% | 140.95% | 53.58% | 41.95% | -57.21% |
BMRN BioMarin Pharmaceutical Inc. | -4.95% | -9.58% | -31.83% | -6.83% | 17.14% | 0.75% | 3.71% | -0.70% | -4.51% | 7.64% |
Fundamentals
RCKT:
$397.82M
BMRN:
$11.15B
RCKT:
-$2.01
BMRN:
$1.79
RCKT:
1.44
BMRN:
1.83
RCKT:
$0.00
BMRN:
$3.22B
RCKT:
$0.00
BMRN:
$2.48B
RCKT:
-$231.75M
BMRN:
$613.03M
Returns By Period
In the year-to-date period, RCKT achieves a 1.99% return, which is significantly higher than BMRN's -4.95% return. Over the past 10 years, RCKT has underperformed BMRN with an annualized return of -19.29%, while BMRN has yielded a comparatively higher -3.97% annualized return.
RCKT
- 1D
- 3.92%
- 1M
- -28.54%
- YTD
- 1.99%
- 6M
- 9.82%
- 1Y
- -46.33%
- 3Y*
- -40.66%
- 5Y*
- -39.78%
- 10Y*
- -19.29%
BMRN
- 1D
- 3.10%
- 1M
- -8.49%
- YTD
- -4.95%
- 6M
- 4.30%
- 1Y
- -20.09%
- 3Y*
- -16.56%
- 5Y*
- -6.21%
- 10Y*
- -3.97%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RCKT vs. BMRN — Risk / Return Rank
RCKT
BMRN
RCKT vs. BMRN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rocket Pharmaceuticals, Inc. (RCKT) and BioMarin Pharmaceutical Inc. (BMRN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RCKT | BMRN | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.42 | -0.57 | +0.14 |
Sortino ratioReturn per unit of downside risk | 0.16 | -0.70 | +0.87 |
Omega ratioGain probability vs. loss probability | 1.03 | 0.92 | +0.11 |
Calmar ratioReturn relative to maximum drawdown | -0.75 | -0.77 | +0.02 |
Martin ratioReturn relative to average drawdown | -0.99 | -1.07 | +0.08 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RCKT | BMRN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.42 | -0.57 | +0.14 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.51 | -0.19 | -0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.23 | -0.11 | -0.12 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.16 | 0.11 | -0.27 |
Correlation
The correlation between RCKT and BMRN is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
RCKT vs. BMRN - Dividend Comparison
Neither RCKT nor BMRN has paid dividends to shareholders.
Drawdowns
RCKT vs. BMRN - Drawdown Comparison
The maximum RCKT drawdown since its inception was -96.70%, which is greater than BMRN's maximum drawdown of -90.58%. Use the drawdown chart below to compare losses from any high point for RCKT and BMRN.
Loading graphics...
Drawdown Indicators
| RCKT | BMRN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.70% | -90.58% | -6.12% |
Max Drawdown (1Y)Largest decline over 1 year | -70.91% | -24.68% | -46.23% |
Max Drawdown (5Y)Largest decline over 5 years | -95.24% | -56.12% | -39.12% |
Max Drawdown (10Y)Largest decline over 10 years | -96.46% | -60.73% | -35.73% |
Current DrawdownCurrent decline from peak | -94.93% | -62.12% | -32.81% |
Average DrawdownAverage peak-to-trough decline | -68.09% | -45.39% | -22.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 53.33% | 19.57% | +33.76% |
Volatility
RCKT vs. BMRN - Volatility Comparison
Rocket Pharmaceuticals, Inc. (RCKT) has a higher volatility of 33.33% compared to BioMarin Pharmaceutical Inc. (BMRN) at 8.06%. This indicates that RCKT's price experiences larger fluctuations and is considered to be riskier than BMRN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RCKT | BMRN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 33.33% | 8.06% | +25.27% |
Volatility (6M)Calculated over the trailing 6-month period | 57.42% | 25.04% | +32.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 110.77% | 35.67% | +75.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 78.25% | 32.21% | +46.04% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 84.16% | 35.65% | +48.51% |
Financials
RCKT vs. BMRN - Financials Comparison
This section allows you to compare key financial metrics between Rocket Pharmaceuticals, Inc. and BioMarin Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities